Brief: Harrow Health Acquires Eye Surgery Trial Drug From Wakamoto Pharmaceutical
18/08/2021 12:40
Aug 18 (Reuters) - Harrow Health Inc HROW.O :
* HARROW HEALTH INC - ACQUIRES OPHTHALMIC SURGICAL DRUG
CANDIDATE
FROM WAKAMOTO PHARMACEUTICAL CO., LTD
* HARROW HEALTH INC - AGREEMENT WITH WAKAMOTO PHARMACEUTICAL
CO.,
LTD. TO ACQUIRE U.S. AND CANADIAN COMMERCIAL RIGHTS FOR DRUG
CANDIDATE MAQ-100
Source text for Eikon: ID:nBw5PGdcpa
Further company coverage: HROW.O
((Reuters.Briefs@thomsonreuters.com;))